Can Lyrica (pregabalin) cause tiredness and dizziness, leading to feelings of wobbliness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Lyrica Cause Tiredness and Wobbliness?

Yes, Lyrica (pregabalin) commonly causes both tiredness (somnolence) and wobbliness (dizziness), which are among its most frequent and characteristic side effects. These symptoms occur in a substantial proportion of patients and are dose-dependent, typically beginning shortly after starting the medication.

Frequency and Characteristics of These Side Effects

Dizziness (Wobbliness)

  • Dizziness occurs in 23-46% of patients taking pregabalin, compared to only 8% on placebo in controlled trials 1, 2
  • The sensation of wobbliness stems from dizziness, which can impair balance and coordination 1
  • Dizziness is the most common adverse reaction leading to treatment withdrawal (4% of patients) 2
  • In 30% of patients who experience dizziness, the symptom persists until the last dose of treatment 2

Tiredness (Somnolence)

  • Somnolence affects 15-25% of pregabalin-treated patients, compared to 8% on placebo 1, 2
  • Somnolence is also one of the most frequent reasons for discontinuing pregabalin (4% withdrawal rate) 2
  • In 42% of patients experiencing somnolence, the symptom persists throughout treatment 2

Dose-Dependent Nature

Both dizziness and somnolence are clearly dose-dependent, meaning higher doses cause these side effects more frequently 2, 3:

  • At 300 mg/day: dizziness occurs in 13-29% of patients, somnolence in 11-16% 1
  • At 600 mg/day: dizziness occurs in 22-35% of patients, somnolence in 15-25% 1

Timing and Management

Onset

  • These side effects generally begin shortly after initiating pregabalin therapy 2
  • Symptoms typically appear within the first week of treatment 2

Management Strategies

  • Both dizziness and somnolence can be managed by dose reduction without necessarily discontinuing therapy 4, 3
  • Starting at the lowest possible dose (75 mg at bedtime or 50 mg three times daily) and increasing gradually minimizes these effects 1, 4
  • For elderly patients or those with renal impairment, even lower starting doses (25-50 mg/day) with slower titration are recommended 1, 4

Critical Safety Warnings

Impairment of Function

  • Pregabalin-related dizziness and somnolence may impair the ability to perform tasks such as driving or operating machinery 2
  • Patients should be explicitly warned not to drive or work with machines until they know how pregabalin affects them 2

Increased Risk with Other Medications

  • The risk of dizziness and sleepiness is significantly higher when pregabalin is combined with opioid pain medications, benzodiazepines, or other CNS depressants 2
  • Alcohol consumption while taking pregabalin increases side effects including sleepiness and dizziness 2

Fall Risk in Elderly Patients

  • Elderly patients are particularly vulnerable to falls, confusion, and sedation from pregabalin 1, 4
  • The combination of dizziness and somnolence creates an unacceptable fall risk in older adults 1

Common Pitfalls to Avoid

  • Do not assume these side effects will resolve on their own without dose adjustment - while tolerance may develop in some patients within a few weeks 5, persistent symptoms require dose reduction 4, 3
  • Do not combine pregabalin with gabapentin thinking it will reduce side effects - both medications have identical adverse effect profiles and create additive sedative burden 1, 4
  • Do not abruptly discontinue pregabalin if side effects are intolerable - taper gradually over at least one week to avoid withdrawal symptoms 2
  • Do not overlook renal function - pregabalin is 85-98% renally excreted, and failure to adjust doses in renal impairment dramatically increases side effects 1, 6

References

Guideline

Pregabalin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Pregabalin--profile of efficacy and tolerability in neuropathic pain].

Drugs of today (Barcelona, Spain : 1998), 2009

Guideline

Management of Pregabalin-Induced Dizziness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pregabalin: new drug. Very similar to gabapentin.

Prescrire international, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.